The patient spends just over fifteen minutes in the tunnel.. 7-Tesla ultra-high-field MRI facilitates more accurate diagnosis of breast cancer, says study Taking part in a recently available study, scientists in the MedUni Vienna possess demonstrated for the first time globally that 7-Tesla ultra-high-subject magnetic resonance imaging can be used for scientific applications in individuals with breast tumours. The scientists' work has been released in the extremely respected journal European Radiology . In previous research concerning 7-Tesla MRI, the exploration of clinical application has previously been limited by just one breast because of the limited coil technology available. The new generation of coils allows scientific application on both sides, explains Katja Pinker from the University Section of Radiology and Nuclear Medication, Division of Molecular Imaging at the MedUni Vienna , which carried out the study in collaboration with the Large Field MR Centre of Excellence and the Breast Health Centre at the MedUni Vienna and Vienna General Hospital .Surgeon-scientist Dr. Catherine O'Brien, senior co-author of the analysis says: The clinical potential of this research is exciting since it maps a viable way to build up targeted treatment for cancer of the colon patients. It is already known that about 65 percent have the BMI-1 biomarker. With the prospective identified, and a successful way to tackle it, this knowledge could readily translate into first-in-human trials to provide more personalized cancer medication. The extensive research was funded by, Genome Canada through the Ontario Genomics Institute, the Ontario Institute for Canada Analysis and a Premier's Summit Award with money from the Province of Ontario, the Canadian Institutes of Health Research, the Canada Study Chair Program, the Ontario Ministry of Health and Long-Term Care, and The Princess Margaret Cancer tumor Foundation.